Auditory system

Here Comes a Sound of Change - Nothing ear (1)

Retrieved on: 
Tuesday, July 27, 2021
Sound, Classical mechanics, Audio engineering, Audiology, Noise reduction, Fields of mathematics, Noise control, Auditory system, Active noise control, NOiSE, Ear, Microphone

Nothing like you've seen before, the raw beauty of ear (1)'s stripped down aesthetic features transparency to expose the engineering, including microphones, magnets and circuit board.

Key Points: 
  • Nothing like you've seen before, the raw beauty of ear (1)'s stripped down aesthetic features transparency to expose the engineering, including microphones, magnets and circuit board.
  • Not only does it look distinct, ear (1) was designed for advanced comfort.
  • Active Noise Cancellation on ear (1) uses three high definition mics to bring your music, films, and podcasts into sharp focus.
  • For loud and clear calls, Clear Voice Technology was specially-developed for ear (1) to reduce distractive background noise, like wind.

Auris Medical Announces Launch of New Corporate Website

Retrieved on: 
Friday, July 16, 2021
Auris, Auditory system, Ear, Inner ear

Hamilton, Bermuda, July 15, 2021 Auris Medical Holding Ltd. (NASDAQ: EARS), a company dedicated to addressing unmet medical needs through RNA therapeutics, allergy and viral infection protection, and inner ear therapeutics, today announced the launch of its newly-designed corporate website www.aurismedical.com .

Key Points: 
  • Hamilton, Bermuda, July 15, 2021 Auris Medical Holding Ltd. (NASDAQ: EARS), a company dedicated to addressing unmet medical needs through RNA therapeutics, allergy and viral infection protection, and inner ear therapeutics, today announced the launch of its newly-designed corporate website www.aurismedical.com .
  • Auris Medical is dedicated to developing therapeutics that address important unmet medical needs.
  • The shares of Auris Medical Holding Ltd. trade on the NASDAQ Capital Market under the symbol EARS.
  • All forward-looking statements and all subsequent written and oral forward-looking statements attributable to Auris Medical or to persons acting on behalf of Auris Medical are expressly qualified in their entirety by reference to these risks and uncertainties.

Fireworks Safety: ASHA Urges Hearing Protection This July 4th

Retrieved on: 
Monday, June 28, 2021
Nervous system, Occupational safety and health, Auditory system, Audiology, Medical specialties, Noise control, Protective gear, Otorhinolaryngology, Earplug, Hearing aid, Hearing protection device, Hearing

According to the Consumer Product Safety Commission, 16% of fireworks injuries are to the head, face, and ears.

Key Points: 
  • According to the Consumer Product Safety Commission, 16% of fireworks injuries are to the head, face, and ears.
  • Yet hearing protection is largely overlooked in advice to the public on holiday safety, much of which is centered on obvious physical injuries such as burns.
  • ASHA advises the following:
    Use hearing protection.Basic earplugs offer good protection for most teens and adults.
  • Audiologists specialize in preventing and assessing hearing and balance disorders as well as providing audiologic treatment, including hearing aids.

As Hearables Sector Matures, Nuheara Deepens Audiology, Hearing Health and Product Development Credentials

Retrieved on: 
Tuesday, June 22, 2021
Nervous system, Sensory systems, Auditory system, Sound, Medical specialties, Audiology, Hearing, Otology, Hearables

The augmented hearables pioneer is at the forefront of bringing affordable and accessible hearing solutions to the mass market with its IQbuds product range.

Key Points: 
  • The augmented hearables pioneer is at the forefront of bringing affordable and accessible hearing solutions to the mass market with its IQbuds product range.
  • The senior leadership appointments include:
    Kat Penno - Director of Hearing Health - will lead Nuhearas range of innovative hearing health services that will be deeply integrated into its overall consumer offering.
  • Formerly, Kat was the president and founder of The Hearing Collective, which provides hearing consultations for businesses.
  • With this expanded team from clinical audiology, product development and global hearing industry leadership, Nuheara is set to continue its disruptive journey in the hearing health space.

Port Washington Hearing Aid Expert Returns to Full Operation with Free Screenings for Community

Retrieved on: 
Wednesday, June 9, 2021
Audiology, Otorhinolaryngology, Nervous system, Hearing, Occupational safety and health, Otology, Auditory system, Sound, Hearing aid, Tinnitus

According to Behrmann, I Love Hearing's Port Washington office is a "real staple" in the tight-knit Long Island community going back about 20 years.

Key Points: 
  • According to Behrmann, I Love Hearing's Port Washington office is a "real staple" in the tight-knit Long Island community going back about 20 years.
  • I Love Hearing's Port Washington office is located at 191 Main Street, near the Port Washington Public Library.
  • I Love Hearing offers hearing aid fittings, hearing aid service, hearing aid testing, hearing protection products, hearing aid accessories, hearing aid classes and workshops, tinnitus therapy, and ear wax management under the care of experienced hearing professionals.
  • I Love Hearing sells nearly every brand on the market, and services all brands of hearing aids and hearing protection.

Healthmonix Lauches Audiology QCDR for MIPS Participation

Retrieved on: 
Thursday, June 3, 2021
Medical specialties, Audiology, Nervous system, Otorhinolaryngology, Otology, Auditory system, Sound, Acoustics, Tinnitus, Cochlear implant, Hearing

QCDR measures have successfully been developed for the Audiology Clinical Registry that address hearing loss, tinnitus, balance disorders, and cochlear implants.

Key Points: 
  • QCDR measures have successfully been developed for the Audiology Clinical Registry that address hearing loss, tinnitus, balance disorders, and cochlear implants.
  • We are excited to present Healthmonix's Audiology Clinical Registry as an improved MIPS pathway for audiologists.
  • "We are excited to present Healthmonix's Audiology Clinical Registry as an improved pathway for audiologists to participate in MIPS," says Healthmonix CEO Lauren Patrick.
  • With MIPSpro, a Top 5 CMS MIPS Qualified Registry & QCDR, Healthmonix has reported to CMS for over 50,000 providers.

Preceptis Medical Launches Next-Generation Hummingbird Tympanostomy Tube System for In-Office Pediatric Ear Tube Procedures

Retrieved on: 
Wednesday, June 2, 2021
Medical devices, Health, Consumer, Surgery, Children, General Health, Ear surgery, Otorhinolaryngology, Clinical medicine, Medical specialties, Auditory system, Myringotomy, Tympanostomy tube, Surgery

Preceptis Medical, Inc ., an innovative surgical technology company dedicated to providing less invasive options for pediatric patients, today announced the launch of their next-generation Hummingbird Tympanostomy Tube System (TTS) for office-based pediatric ear tube procedures.

Key Points: 
  • Preceptis Medical, Inc ., an innovative surgical technology company dedicated to providing less invasive options for pediatric patients, today announced the launch of their next-generation Hummingbird Tympanostomy Tube System (TTS) for office-based pediatric ear tube procedures.
  • The next-generation Hummingbird device features an enhanced ergonomic design that allows for a more efficient ear tube delivery in children.
  • In-office pediatric ear tube procedures using the Hummingbird are increasingly becoming more sought after by parents.
  • The Hummingbird device uniquely combines the separate tools and steps performed in standard ear tube procedures into one comprehensive device.

Auris Medical Starts Preparations for Covid-19 Trial with Bentrio in India

Retrieved on: 
Tuesday, June 1, 2021
Branches of biology, Nervous system, Sensory systems, Auditory system, Auris, Otology, Otorhinolaryngology, Occupational safety and health, Neurotology, Ear, Tinnitus, Inner ear

Auris Medical is a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology, rhinology and allergy and CNS disorders.

Key Points: 
  • Auris Medical is a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology, rhinology and allergy and CNS disorders.
  • In addition, Auris Medical has two Phase 3 programs under development: Sonsuvi (AM-111) for acute inner ear hearing loss and Keyzilen (AM-101) for acute inner ear tinnitus.
  • The shares of Auris Medical Holding Ltd. trade on the NASDAQ Capital Market under the symbol EARS.
  • All forward-looking statements and all subsequent written and oral forward-looking statements attributable to Auris Medical or to persons acting on behalf of Auris Medical are expressly qualified in their entirety by reference to these risks and uncertainties.

Juntendo University research: Step forward towards treating hereditary deafness

Retrieved on: 
Monday, May 31, 2021
Branches of biology, Auditory system, Biology, Connexins, Life sciences, Ear, Induced stem cells, Biotechnology, GJB2, Cochlea, Stem cell, Inner ear

One way of treating GJB2-related deafness would be to reproduce properly functioning cochlear cells and introduce them into the inner ear.

Key Points: 
  • One way of treating GJB2-related deafness would be to reproduce properly functioning cochlear cells and introduce them into the inner ear.
  • Now, Kazusaku Kamiya from Juntendo University and colleagues have made an important step forward toward making this treatment possible: using a stem-cell technique, they succeeded in reproducing cochlear supporting cells, a type of cell known to contain CX26 proteins.
  • Kazusaku Kamiya from Juntendo University and colleagues have now applied the iPSC technique to provide insights into a common type of deafness in newborns.
  • They succeeded in creating cells functioning like cochlear supporting cells, a promising step forward to developing a replacement therapy for malfunctioning supporting cells.

Juntendo University research: Step forward towards treating hereditary deafness

Retrieved on: 
Monday, May 31, 2021
Branches of biology, Auditory system, Biology, Connexins, Life sciences, Ear, Induced stem cells, Biotechnology, GJB2, Cochlea, Stem cell, Inner ear

One way of treating GJB2-related deafness would be to reproduce properly functioning cochlear cells and introduce them into the inner ear.

Key Points: 
  • One way of treating GJB2-related deafness would be to reproduce properly functioning cochlear cells and introduce them into the inner ear.
  • Now, Kazusaku Kamiya from Juntendo University and colleagues have made an important step forward toward making this treatment possible: using a stem-cell technique, they succeeded in reproducing cochlear supporting cells, a type of cell known to contain CX26 proteins.
  • Kazusaku Kamiya from Juntendo University and colleagues have now applied the iPSC technique to provide insights into a common type of deafness in newborns.
  • They succeeded in creating cells functioning like cochlear supporting cells, a promising step forward to developing a replacement therapy for malfunctioning supporting cells.